We have evaluated the efficacy of Nedocromil sodium 1% nasal solution in 36 patients (20 females and 16 males, mean age 29.5 years) suffering from perennial allergic rhinitis caused by Dermatophagoides pteronyssinus. Nedocromil sodium was given four times a day for 2 months. On a daily card patients had to report the severity of the considered symptoms (runny, nose, sneezing, itchy nose and stuffy nose) following an arbitrary score from 0 to 3 (0 = no symptom, 1 = mild, 2 = moderate, 3 = severe). Clinical evaluation was performed after 1 month and at the end of the treatment. We observed a statistically significant decrease of the considered symptoms already after a one month therapy. This improvement was higher after two months (p lt 0.001...
Background: Treatment with intranasal olopatidine hydrochloride spray is proposed for patients with ...
A 3-month double-blind group comparative trial of nedocromil sodium (4 mg twice daily) and placebo w...
Bronchial hyperresponsiveness (BHR) to methacholine was studied in 14 patients with asthma and five ...
We have evaluated the efficacy of nedocromil sodium 1% nasal spray in 29 patients (14 males and 15 f...
We have evaluated the efficacy of nedocromil sodium in 38 patients (18 males and 20 females, mean ag...
We have evaluated the efficacy of nedocromil sodium 2% eye drops in 35 patients (18 males and 17 fem...
Inhaled nedocromil sodium was administered 4 times a day for 8 weeks to 34 patients (20 males and 14...
Thirty-two patients (20 males and 12 females, mean age 31 ys) with seasonal allergic conjunctivitis ...
The safety, acceptability and efficacy of nedocromil sodium, given by metered dose inhaler at a dosa...
Background - Nedocromil sodium, a nonsteroidal anti-inflammatory drug, is effective in the treatment...
In a double-blind, double-placebo, randomized crossover study, we compared the effects of 6 wk of tr...
The clinical picture of allergic rhinitis includes sneezing, nasal discharge, impaired nasal breathi...
Background: A nasal spray containing the antiallergy agent olopatadine hydrochloride is being develo...
The effect of long-term treatment with sodium nedocromil on airway hypereactivity was investigated i...
A double-masked, randomised, placebo-controlled study was conducted to evaluate the effectiveness of...
Background: Treatment with intranasal olopatidine hydrochloride spray is proposed for patients with ...
A 3-month double-blind group comparative trial of nedocromil sodium (4 mg twice daily) and placebo w...
Bronchial hyperresponsiveness (BHR) to methacholine was studied in 14 patients with asthma and five ...
We have evaluated the efficacy of nedocromil sodium 1% nasal spray in 29 patients (14 males and 15 f...
We have evaluated the efficacy of nedocromil sodium in 38 patients (18 males and 20 females, mean ag...
We have evaluated the efficacy of nedocromil sodium 2% eye drops in 35 patients (18 males and 17 fem...
Inhaled nedocromil sodium was administered 4 times a day for 8 weeks to 34 patients (20 males and 14...
Thirty-two patients (20 males and 12 females, mean age 31 ys) with seasonal allergic conjunctivitis ...
The safety, acceptability and efficacy of nedocromil sodium, given by metered dose inhaler at a dosa...
Background - Nedocromil sodium, a nonsteroidal anti-inflammatory drug, is effective in the treatment...
In a double-blind, double-placebo, randomized crossover study, we compared the effects of 6 wk of tr...
The clinical picture of allergic rhinitis includes sneezing, nasal discharge, impaired nasal breathi...
Background: A nasal spray containing the antiallergy agent olopatadine hydrochloride is being develo...
The effect of long-term treatment with sodium nedocromil on airway hypereactivity was investigated i...
A double-masked, randomised, placebo-controlled study was conducted to evaluate the effectiveness of...
Background: Treatment with intranasal olopatidine hydrochloride spray is proposed for patients with ...
A 3-month double-blind group comparative trial of nedocromil sodium (4 mg twice daily) and placebo w...
Bronchial hyperresponsiveness (BHR) to methacholine was studied in 14 patients with asthma and five ...